company background image
600511 logo

China National Medicines SHSE:600511 Stock Report

Last Price

CN¥33.70

Market Cap

CN¥25.4b

7D

4.7%

1Y

4.1%

Updated

31 Jul, 2024

Data

Company Financials +

China National Medicines Corporation Ltd.

SHSE:600511 Stock Report

Market Cap: CN¥25.4b

China National Medicines Corporation Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China National Medicines
Historical stock prices
Current Share PriceCN¥33.70
52 Week HighCN¥37.80
52 Week LowCN¥26.58
Beta0.32
11 Month Change6.81%
3 Month Change-3.02%
1 Year Change4.08%
33 Year Change1.41%
5 Year Change40.36%
Change since IPO950.39%

Recent News & Updates

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Recent updates

Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

Jul 28
Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture

China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

Jun 24
China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement

China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Jun 07
China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854

Is China National Medicines (SHSE:600511) Using Too Much Debt?

Jun 05
Is China National Medicines (SHSE:600511) Using Too Much Debt?

Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

May 21
Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

Shareholder Returns

600511CN HealthcareCN Market
7D4.7%-1.6%-0.8%
1Y4.1%-37.2%-21.8%

Return vs Industry: 600511 exceeded the CN Healthcare industry which returned -37.2% over the past year.

Return vs Market: 600511 exceeded the CN Market which returned -21.8% over the past year.

Price Volatility

Is 600511's price volatile compared to industry and market?
600511 volatility
600511 Average Weekly Movement3.6%
Healthcare Industry Average Movement4.9%
Market Average Movement5.6%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 600511 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600511's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19993,138Guotao Tianwww.cncm.com.cn

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions.

China National Medicines Corporation Ltd. Fundamentals Summary

How do China National Medicines's earnings and revenue compare to its market cap?
600511 fundamental statistics
Market capCN¥25.43b
Earnings (TTM)CN¥2.19b
Revenue (TTM)CN¥50.59b

11.6x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600511 income statement (TTM)
RevenueCN¥50.59b
Cost of RevenueCN¥46.61b
Gross ProfitCN¥3.98b
Other ExpensesCN¥1.79b
EarningsCN¥2.19b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 22, 2024

Earnings per share (EPS)2.90
Gross Margin7.87%
Net Profit Margin4.33%
Debt/Equity Ratio1.0%

How did 600511 perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

29%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.